Skip to content

Lifting up patients through community engagement and research to unlock the cure to melanoma of all types.

Exciting melanoma research funding update:

We have just learned that House Appropriations Committee Subcommittee on Defense Chair Ken Calvert (CA-41) and Senate Appropriations Committee Subcommittee on Defense Chair Mitch McConnell issued a letter to Department of Defense Secretary, Pete Hegseth, indicating Congressional intent for CDMRP FY25 programs. Contained in that letter was the directive to fund the Melanoma Research Program (MRP) at $40 million for FY25! This funding will enable more research and more melanoma treatment progress for military members and the general public. According to a recent Military Medicine Study, melanoma incidence among service members is 62% greater than civilians and this program seeks to minimize incidence rates across both populations!

This major achievement is a direct result of your advocacy over the past month! An incredible 206 advocates with 248 calls to Congress (House and Senate), 50 advocates who went to Capitol Hill, 14 advocacy organizations and 32 researchers who signed an FY25 sign on letter. We are so appreciative of the #melanoma community and your efforts to help protect this vital research funding, and we thank Congressional Appropriators for continued melanoma research funding.

 

While we are optimistic about the future of melanoma funding through the Congressionally Directed Medical Research Program (CDMRP), we are disappointed to learn of the cuts to the 23 other deserving programs within the CDMRP. 

 

The MRF will continue to advocate for melanoma research funding and finding ways to engage patients and caregivers with their lawmakers.

Decorative Spiral

The MRF’s mission is to eradicate melanoma by accelerating medical research while educating and advocating for the melanoma community.

Why We Fight.

Melanoma is the deadliest form of skin cancer.

8,290+

Melanoma claims the lives of over 8,290 Americans every year

25-30

Leading cause of cancer death in young women ages 25 – 30

90%

9 out of 10 cases are considered to be preventable

Our Impact

Funding Melanoma Research

27

Clinical Trials

132

Grants With New Collaborations

276

Published Articles

591

Webinars & Presentations

Mar 31, 2025

2025 Eyes on a Cure Ocular Melanoma Patient and Caregiver Symposium Information Meeting

Apr 05, 2025

Fred Hutch Cancer Center Patient Symposium

Mar 31, 2025

2025 Eyes on a Cure Ocular Melanoma Patient and Caregiver Symposium Information Meeting

Apr 05, 2025

Fred Hutch Cancer Center Patient Symposium

Apr 07, 2025

UNC Lineberger Comprehensive Cancer Center Patient Symposium

Apr 26, 2025 – Apr 27, 2025

Eyes on a Cure: Ocular Melanoma Patient & Caregiver Symposium

May 10, 2025

The Ohio State University Patient and Caregiver Symposium

All Events

Medical Student Award

Jaclyn Roland-McGowan

2025

A/B Testing of Patient Decision Aids for Dysplastic Nevi Treatment

Medical Student Award

Jack Kollings

2025

Boosting Melanoma Immunity with Sequential IL-2 and IL-12 Gene Delivery

Medical Student Award

Amanda Zucker

2025

Multimodal Tumor Measurements for Advancing Uveal Melanoma Diagnostics

Medical Student Award

Marin Melloy

2025

Comparing mutational landscape of melanoma across racial and ethnic groups

Medical Student Award

Kimberly Nguyen

2025

Defining drivers and metastatic risk of AP-1 heterogeneity in melanoma

Medical Student Award

Haarisudhan Sureshkumar

2025

Environmental Factors and Social Determinants of Health in Uveal Melanoma

Medical Student Award

Julyssa Renteria

2025

Genetic Drivers of Cutaneous Melanoma: Racial Disparities in Mutations

Medical Student Award

Hannah Wu

2025

Investigating T cell tolerance in nevi and its role in melanoma prevention

Medical Student Award

Zachary Walsh

2025

Leveraging T cell genetic variants to enhance melanoma immunotherapies

Medical Student Award

Anjali Devireddy

2025

Mitigating Local Recurrence Risk for Melanoma Patients with Microsatellites

Patient Resources

The MRF is committed to providing the most up-to-date education and support resources for melanoma patients and their loved ones.

Find a Treatment Center

Although the MRF cannot recommend a specific doctor, clinic or clinical trial, the Melanoma Treatment Center Finder and Clinical Trial Finder will help you find an experienced melanoma treatment team, as well as give you the opportunity to explore clinical trials. Did you know that clinical trials are often viewed as the best treatment option for Stage II, III and IV melanoma patients? Please remember to use this information as a starting point in your search for a healthcare team that best meets your needs. All information regarding your treatment should be discussed with your healthcare professional.

Decorative Spiral

Shop & Support Our Mission

Grab some merch to support our mission to eradicate melanoma by accelerating medical research while educating and advocating for the melanoma community.

Shop Products